CREDIT SUISSE AG/ - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$421,791
-20.1%
23,485
-9.5%
0.00%
-100.0%
Q2 2023$527,782
+14.1%
25,948
+22.1%
0.00%
Q1 2023$462,618
-23.0%
21,260
+9.7%
0.00%
-100.0%
Q4 2022$600,586
+70.1%
19,380
+40.1%
0.00%
Q3 2022$353,000
+26.5%
13,831
+0.7%
0.00%
Q2 2022$279,000
-21.6%
13,735
-4.7%
0.00%
Q1 2022$356,000
-30.3%
14,415
-2.0%
0.00%
Q4 2021$511,000
+37.7%
14,703
+7.7%
0.00%
Q3 2021$371,000
+33.9%
13,649
+28.1%
0.00%
Q2 2021$277,000
-41.3%
10,658
-51.3%
0.00%
Q1 2021$472,000
-46.5%
21,896
-46.7%
0.00%
Q4 2020$882,000
+31.1%
41,090
-9.9%
0.00%
Q3 2020$673,000
-59.8%
45,629
-39.1%
0.00%
-100.0%
Q2 2020$1,675,000
+87.4%
74,966
+18.5%
0.00%0.0%
Q1 2020$894,000
-18.0%
63,245
-5.7%
0.00%0.0%
Q4 2019$1,090,000
+45.1%
67,091
+212.7%
0.00%0.0%
Q3 2019$751,000
-63.0%
21,453
-40.4%
0.00%
-50.0%
Q2 2019$2,032,000
+85.7%
36,012
+140.6%
0.00%
+100.0%
Q1 2019$1,094,000
+24.6%
14,968
+8.8%
0.00%0.0%
Q4 2018$878,000
+29.1%
13,761
+101.9%
0.00%0.0%
Q3 2018$680,000
-19.2%
6,816
-42.4%
0.00%0.0%
Q2 2018$842,000
-38.2%
11,842
-9.5%
0.00%0.0%
Q1 2018$1,362,000
-17.4%
13,085
-20.0%
0.00%0.0%
Q4 2017$1,648,000
+408.6%
16,363
+76.1%
0.00%
Q3 2017$324,0009,2900.00%
Other shareholders
ANAPTYSBIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders